CSL Limited (ASX:CSL) shares jump 2.6% as healthcare bounces; three dates investors circle
CSL Limited shares rose 2.6% to A$174.45 Thursday but remain down 39% over the past year. The S&P/ASX 200 closed up 0.3% as healthcare stocks rebounded and bond yields eased. CSL’s outlook remains clouded after it cut its 2026 revenue forecast and delayed a flu vaccine unit spin-off due to weak U.S. demand. The RBA’s next rate decision is set for Feb. 3.